The overall sensitivity detected for each tumor marker was as follows: for urine cytology was 75.9% and UCyt+TM was 83.3%, for CK20 70.4%, while the specificity was 66.7% for urine cytology and 86.1% for UCyt+TM and 83.3% for CK20. The gene discussed is KRT20; the disease is neoplasm.